Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.36 |
| ▸ | CCNC | P24863 | 1/20 | 0.36 |
| ▸ | CDK8 | P49336 | 1/20 | 0.36 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30957166 | 0.83 | SIRT3 (0.61) | TDP1SIRT3ALDH1A1KDM4EGLA | |
| SCHEMBL1440123 | 0.83 | SIRT3 (0.61) | TDP1SIRT3ALDH1A1KDM4EGLA | |
| SCHEMBL5802324 | 0.81 | TDP1 (0.59) | TDP1SIRT3ALDH1A1KDM4EGLA | |
| SCHEMBL4591568 | 0.81 | TDP1 (0.65) | TDP1SIRT3ALDH1A1KDM4EGLA | |
| SCHEMBL29570949 | 0.80 | SIRT3 (0.58) | TDP1SIRT3ALDH1A1NPC1RAB9A | |
| SCHEMBL907851 | 0.80 | SIRT3 (0.58) | TDP1SIRT3ALDH1A1NPC1RAB9A | |
| SCHEMBL2905999 | 0.79 | ALDH1A1 (0.44) | TDP1SIRT3ALDH1A1KDM4EGLA | |
| Ethane SCHEMBL28930003 | 0.79 | SIRT3 (0.56) | TDP1SIRT3ALDH1A1NPC1RAB9A | |
| SCHEMBL28101840 | 0.79 | TDP1 (0.56) | TDP1SIRT3ALDH1A1KDM4EGLA | |
| SCHEMBL6180804 | 0.79 | TDP1 (0.66) | TDP1SIRT3ALDH1A1KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110267954-A | 1,2- pyrrolin simultaneously [3,4-c] pyridine/pyrimidine -3- ketone derivatives and the purposes that aniline replaces | 上海海雁医药科技有限公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-109790143-A | Amine-linked C for target protein degradation3-glutarimide solution stator body | C4医药公司 | 2019-05-21 | — | — | CN | disclosed |
| CN-108602805-A | Isoindoline, azaisoindoline, indenone and the dihydro azepine indone inhibitor of MNK1 and MNK2 | 效应治疗股份有限公司 | 2018-09-28 | — | — | CN | disclosed |
| US-9765057-B2 | 3-ester-4 substituted orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2017-09-19 | — | — | US | disclosed |
| CN-103814027-B | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and their use as C5A receptor modulators | 诺华股份有限公司 | 2016-07-06 | — | — | CN | disclosed |
| US-20150322040-A1 | 3-ESTER-4 SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2015-11-12 | — | — | US | disclosed |
| EP-2079690-A2 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008038251-A2 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150322040-A1 | 3-ESTER-4 SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS | HCRTR2, HCRTR1, NPY4R | TDP1 4656/4885SIRT3 633/4885ALDH1A1 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.